Target Product Profile: Key to Success in Drug Development

A planning tool introduced by the FDA to streamline the drug development process, a TTP defines the key attributes and paints a picture of an ideal end product—what it does, who it helps, and how it works. In drug development, every stage of development builds on the last and each step is designed to pave the way for what comes next. That is why it is crucial to start drafting the TPP early, even while the science is still taking shape. “The first thing you need to do when you’re filling out a target product profile is to start with the end in mind—to really understand the patient’s clinical problem and what the ideal solution would be to solve that problem,” said Dr. Kevin Grimes, MD, MBA, Chief Clinical and Education Advisor at SPARK NS and a frequent presenter at SPARK NS program updates and courses.

Ideally, a TPP includes information about the target indication, the ideal route of administration and dosing frequency, use with existing therapies, and the preclinical and clinical studies required. It also addresses the intellectual property (IP) status needed to ensure return on investment, available regulatory pathways, and financial considerations. Crucially, the TPP evolves as the program advances. Early versions sketch the big picture, including unmet medical need, desired mechanism of action, pharmacologic characteristics (for example, potency and specificity), and the competitive landscape. Later iterations dig deeper into clinical trial design, safety and toxicity expectations, clinical pharmacology, regulatory strategy, IP risk assessment, and cost projections.

Critical questions research teams should ask when developing aTPP include:

• Will the final product be a small molecule, peptide, antibody, or cell therapy?
• What animal models are available?
• What biomarkers will be used?; What is the desired therapeutic window?
• What accelerated development pathways or designations could be considered?
• What are the desired licensing outcomes and exclusivity rights?
• What is the project pricing and cost to a patient?

“At the end of the day, you want to come up with a document that defines the minimum essential criteria that would be required to develop a successful product,” said Dr. Grimes.

A well-crafted TPP is more than an internal planning tool that guides decision-making and defines objective go/no-go points. It also facilitates clear communication between developers, partners, and regulators.